What Happens When Insurance Companies Become More Powerful Than Medicine?

By MATTHEW ZACHARY The American healthcare system behaves exactly as its incentives tell it to behave. That sentence sounds almost boring until you follow it to its logical conclusion. Insurance companies now influence clinical decisions more aggressively than many physicians. They shape hospital consolidation. They determine startup viability. They influence venture capital allocation. They dictate…

Read More

The Scientific Frontier of Ingestible Sensors

Ingestible sensors are emerging as a promising frontier in gastroenterology, offering a minimally invasive way to monitor the gastrointestinal (GI) tract in real time. Instead of relying solely on endoscopy or colonoscopy—which are costly, invasive, and often avoided by patients—swallowable devices can capture biochemical signals such as gases and redox balance as they pass through…

Read More

What Will the Next Healthcare Exit Winners Look Like?

Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models. The post What Will the Next Healthcare Exit Winners Look Like? appeared first on MedCity News.

Read More

New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research Hospitals Can Seize the Moment

Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For any hospital considering adopting these new solutions, here are some of the key questions and considerations that should be top of mind. The post New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research…

Read More